ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Therapeutic advances in non-alcoholic fatty liver disease: A microbiota-centered view

Chen, Hui-Ting; Huang, Hong-Li; Li, Yong-Qiang; Xu, Hao-Ming; Zhou, Yong-Jian*广州医学院; 1
WORLD JOURNAL OF GASTROENTEROLOGY2020-4-28DOI: 10.3748/wjg.v26.i16.1901
30被引9阅读
引用收藏
分享

摘要

Non-alcoholic fatty liver disease (NAFLD) is a highly prevalent metabolic disorder with steadily increasing incidence rates worldwide, especially in the West. There are no drugs available at present to treat NAFLD, and the primary therapeutic options include weight loss and the combination of healthy diet and exercise. Therefore, novel interventions are required that can target the underlying risk factors. Gut microbiota is an "invisible organ" of the human body and vital for normal metabolism and immuno-modulation. The number and diversity of microbes differ across the gastrointestinal tract from the mouth to the anus, and is most abundant in the intestine. Since dysregulated gut microbiota is an underlying pathological factor of NAFLD, it is a viable therapeutic target that can be modulated by antibiotics, probiotics, prebiotics, synbiotics, fecal microbiota transplantation, and microbial metabolites. In this review, we summarize the most recent advances in gut microbiota-targeted therapies against NAFLD in clinical and experimental studies, and critically evaluate novel targets and strategies for treating NAFLD.

学科与关键词

关键词
Non-alcoholic fatty liver diseaseGut microbiotaProbioticsPrebioticsFecal microbiota transplantationMetabolites
相关
加载中…
  • The Role of the Intestinal Microbiota in Nonalcoholic Steatohepatitis
    Xiang, Hui*; Sun, Dating; Liu, Xin; She, Zhi-Gang*; Chen, Yonghong*Frontiers in Endocrinology, 2022, 13: 812610.被引 11
  • Current insights in molecular characterization of non-alcoholic fatty liver disease and treatment
    Che, Wensheng; Zhao, Ming; Li, Xiaoqing; Li, Chunlong*; Cho, William C.*; Yu, Shan*Frontiers in Endocrinology, 2022, 13: 1002916.被引 2
  • The Critical Role of microRNA-21 in Non-alcoholic Fatty Liver Disease Pathogenesis
    Liu, Mingjing; Lu, Ting; Bai, Yuanling; Han, Xingyu; Zhang, Wanyi; Zhang, Lei; Chen, Shudan; Lin, Chen; Liu, Chaoqi*; Yuan, Chengfu*Current Pharmaceutical Design, 2023, 29(12): 904-913.
查看全部 →

发表信息

论文状态
公开发表
期刊
WORLD JOURNAL OF GASTROENTEROLOGY
发表日期
2020-04-28
卷期
第 26 卷, 第 16 期
页码
1901-1911
DOI
10.3748/wjg.v26.i16.1901
语言
ENGLISH
期刊收录
NSL.SCIE
期刊等级
3区
成果收录
SCIE
资助标注
Guangzhou General Science and Technology Project of Health and Family Planning [20191A011001]; Guangzhou Planned Project of Science and Technology [201904010132]

作者

  • C

    Chen, Hui-Ting (第一作者)

    1 · guangzhou med univ

  • H

    Huang, Hong-Li

    1 · guangzhou med univ

查看全部 5 位作者收起作者
  • L

    Li, Yong-Qiang

    1 · guangzhou med univ

  • X

    Xu, Hao-Ming

    1 · guangzhou med univ

  • Z

    Zhou, Yong-Jian (通讯)

    1 · guangzhou med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417